nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—Procarbazine—hematologic cancer	0.496	1	CrCtD
Atenolol—Ibuprofen—Procarbazine—hematologic cancer	0.124	0.656	CrCrCtD
Atenolol—ABCB1—hematologic cancer	0.0748	1	CbGaD
Atenolol—Ibuprofen—Melphalan—hematologic cancer	0.0652	0.344	CrCrCtD
Atenolol—ABCB1—Lenalidomide—hematologic cancer	0.0176	0.141	CbGbCtD
Atenolol—ABCB1—Daunorubicin—hematologic cancer	0.0103	0.0826	CbGbCtD
Atenolol—ABCB1—Alitretinoin—hematologic cancer	0.0101	0.0809	CbGbCtD
Atenolol—ABCB1—Imatinib—hematologic cancer	0.0079	0.0633	CbGbCtD
Atenolol—ABCB1—Nilotinib—hematologic cancer	0.00718	0.0575	CbGbCtD
Atenolol—ABCB1—Vinorelbine—hematologic cancer	0.00712	0.057	CbGbCtD
Atenolol—ABCB1—Dasatinib—hematologic cancer	0.00635	0.0508	CbGbCtD
Atenolol—ABCB1—Mitoxantrone—hematologic cancer	0.00627	0.0502	CbGbCtD
Atenolol—ABCB1—Betamethasone—hematologic cancer	0.00559	0.0447	CbGbCtD
Atenolol—ABCB1—Gemcitabine—hematologic cancer	0.00554	0.0443	CbGbCtD
Atenolol—ABCB1—Prednisolone—hematologic cancer	0.00551	0.0442	CbGbCtD
Atenolol—ABCB1—Prednisone—hematologic cancer	0.00521	0.0417	CbGbCtD
Atenolol—ABCB1—Irinotecan—hematologic cancer	0.00494	0.0395	CbGbCtD
Atenolol—ABCB1—Vinblastine—hematologic cancer	0.00439	0.0351	CbGbCtD
Atenolol—ABCB1—Vincristine—hematologic cancer	0.00432	0.0346	CbGbCtD
Atenolol—ABCB1—Cisplatin—hematologic cancer	0.00402	0.0322	CbGbCtD
Atenolol—ABCB1—Etoposide—hematologic cancer	0.00395	0.0317	CbGbCtD
Atenolol—ABCB1—Dexamethasone—hematologic cancer	0.00325	0.026	CbGbCtD
Atenolol—ABCB1—Doxorubicin—hematologic cancer	0.0027	0.0216	CbGbCtD
Atenolol—ABCB1—Methotrexate—hematologic cancer	0.00261	0.0209	CbGbCtD
Atenolol—Acebutolol—SLC22A1—hematologic cancer	0.000195	0.307	CrCbGaD
Atenolol—Ibuprofen—BCL2—hematologic cancer	0.000138	0.217	CrCbGaD
Atenolol—Ibuprofen—UGT1A1—hematologic cancer	0.000117	0.185	CrCbGaD
Atenolol—Acebutolol—ABCB1—hematologic cancer	5.68e-05	0.0893	CrCbGaD
Atenolol—Metoprolol—ABCB1—hematologic cancer	4.79e-05	0.0754	CrCbGaD
Atenolol—Ibuprofen—ALB—hematologic cancer	2.88e-05	0.0453	CrCbGaD
Atenolol—Ibuprofen—ABCB1—hematologic cancer	2.75e-05	0.0432	CrCbGaD
Atenolol—Propranolol—ABCB1—hematologic cancer	2.42e-05	0.038	CrCbGaD
Atenolol—Rash—Ifosfamide—hematologic cancer	1.57e-05	0.000161	CcSEcCtD
Atenolol—Dermatitis—Ifosfamide—hematologic cancer	1.57e-05	0.000161	CcSEcCtD
Atenolol—Hyperhidrosis—Betamethasone—hematologic cancer	1.56e-05	0.00016	CcSEcCtD
Atenolol—Hyperhidrosis—Dexamethasone—hematologic cancer	1.56e-05	0.00016	CcSEcCtD
Atenolol—Dizziness—Irinotecan—hematologic cancer	1.56e-05	0.00016	CcSEcCtD
Atenolol—Malaise—Prednisone—hematologic cancer	1.56e-05	0.00016	CcSEcCtD
Atenolol—Body temperature increased—Etoposide—hematologic cancer	1.55e-05	0.000159	CcSEcCtD
Atenolol—Vertigo—Prednisone—hematologic cancer	1.55e-05	0.000159	CcSEcCtD
Atenolol—Syncope—Prednisone—hematologic cancer	1.55e-05	0.000159	CcSEcCtD
Atenolol—Tinnitus—Methotrexate—hematologic cancer	1.55e-05	0.000158	CcSEcCtD
Atenolol—Anorexia—Betamethasone—hematologic cancer	1.54e-05	0.000158	CcSEcCtD
Atenolol—Anorexia—Dexamethasone—hematologic cancer	1.54e-05	0.000158	CcSEcCtD
Atenolol—Asthenia—Cisplatin—hematologic cancer	1.54e-05	0.000158	CcSEcCtD
Atenolol—Fatigue—Triamcinolone—hematologic cancer	1.54e-05	0.000158	CcSEcCtD
Atenolol—Sweating—Doxorubicin—hematologic cancer	1.53e-05	0.000157	CcSEcCtD
Atenolol—Rash—Vincristine—hematologic cancer	1.53e-05	0.000157	CcSEcCtD
Atenolol—Dermatitis—Vincristine—hematologic cancer	1.53e-05	0.000157	CcSEcCtD
Atenolol—Pain—Triamcinolone—hematologic cancer	1.52e-05	0.000156	CcSEcCtD
Atenolol—Headache—Vincristine—hematologic cancer	1.52e-05	0.000156	CcSEcCtD
Atenolol—Loss of consciousness—Prednisone—hematologic cancer	1.52e-05	0.000156	CcSEcCtD
Atenolol—Hypotension—Dexamethasone—hematologic cancer	1.51e-05	0.000155	CcSEcCtD
Atenolol—Hypotension—Betamethasone—hematologic cancer	1.51e-05	0.000155	CcSEcCtD
Atenolol—Nausea—Carmustine—hematologic cancer	1.51e-05	0.000155	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—hematologic cancer	1.51e-05	0.000155	CcSEcCtD
Atenolol—Nausea—Alitretinoin—hematologic cancer	1.5e-05	0.000153	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—hematologic cancer	1.49e-05	0.000153	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—hematologic cancer	1.49e-05	0.000153	CcSEcCtD
Atenolol—Rash—Irinotecan—hematologic cancer	1.49e-05	0.000153	CcSEcCtD
Atenolol—Rash—Mitoxantrone—hematologic cancer	1.49e-05	0.000153	CcSEcCtD
Atenolol—Dermatitis—Mitoxantrone—hematologic cancer	1.49e-05	0.000153	CcSEcCtD
Atenolol—Dermatitis—Irinotecan—hematologic cancer	1.49e-05	0.000153	CcSEcCtD
Atenolol—Headache—Mitoxantrone—hematologic cancer	1.48e-05	0.000152	CcSEcCtD
Atenolol—Headache—Irinotecan—hematologic cancer	1.48e-05	0.000152	CcSEcCtD
Atenolol—Nausea—Ifosfamide—hematologic cancer	1.48e-05	0.000152	CcSEcCtD
Atenolol—Feeling abnormal—Triamcinolone—hematologic cancer	1.47e-05	0.000151	CcSEcCtD
Atenolol—Diarrhoea—Cisplatin—hematologic cancer	1.47e-05	0.000151	CcSEcCtD
Atenolol—Anxiety—Prednisone—hematologic cancer	1.46e-05	0.00015	CcSEcCtD
Atenolol—Alopecia—Methotrexate—hematologic cancer	1.46e-05	0.00015	CcSEcCtD
Atenolol—Insomnia—Dexamethasone—hematologic cancer	1.46e-05	0.00015	CcSEcCtD
Atenolol—Insomnia—Betamethasone—hematologic cancer	1.46e-05	0.00015	CcSEcCtD
Atenolol—Bradycardia—Doxorubicin—hematologic cancer	1.46e-05	0.00015	CcSEcCtD
Atenolol—Paraesthesia—Betamethasone—hematologic cancer	1.45e-05	0.000149	CcSEcCtD
Atenolol—Paraesthesia—Dexamethasone—hematologic cancer	1.45e-05	0.000149	CcSEcCtD
Atenolol—Discomfort—Prednisone—hematologic cancer	1.45e-05	0.000149	CcSEcCtD
Atenolol—Rash—Gemcitabine—hematologic cancer	1.45e-05	0.000149	CcSEcCtD
Atenolol—Dermatitis—Gemcitabine—hematologic cancer	1.45e-05	0.000149	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—hematologic cancer	1.45e-05	0.000148	CcSEcCtD
Atenolol—Headache—Gemcitabine—hematologic cancer	1.44e-05	0.000148	CcSEcCtD
Atenolol—Nausea—Vincristine—hematologic cancer	1.44e-05	0.000148	CcSEcCtD
Atenolol—Flushing—Epirubicin—hematologic cancer	1.44e-05	0.000148	CcSEcCtD
Atenolol—Dyspepsia—Betamethasone—hematologic cancer	1.42e-05	0.000146	CcSEcCtD
Atenolol—Dyspepsia—Dexamethasone—hematologic cancer	1.42e-05	0.000146	CcSEcCtD
Atenolol—Asthenia—Etoposide—hematologic cancer	1.41e-05	0.000145	CcSEcCtD
Atenolol—Body temperature increased—Triamcinolone—hematologic cancer	1.41e-05	0.000145	CcSEcCtD
Atenolol—Oedema—Prednisone—hematologic cancer	1.41e-05	0.000144	CcSEcCtD
Atenolol—Decreased appetite—Dexamethasone—hematologic cancer	1.41e-05	0.000144	CcSEcCtD
Atenolol—Decreased appetite—Betamethasone—hematologic cancer	1.41e-05	0.000144	CcSEcCtD
Atenolol—Nausea—Irinotecan—hematologic cancer	1.4e-05	0.000144	CcSEcCtD
Atenolol—Nausea—Mitoxantrone—hematologic cancer	1.4e-05	0.000144	CcSEcCtD
Atenolol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.4e-05	0.000143	CcSEcCtD
Atenolol—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.4e-05	0.000143	CcSEcCtD
Atenolol—Fatigue—Dexamethasone—hematologic cancer	1.39e-05	0.000143	CcSEcCtD
Atenolol—Fatigue—Betamethasone—hematologic cancer	1.39e-05	0.000143	CcSEcCtD
Atenolol—Pruritus—Etoposide—hematologic cancer	1.39e-05	0.000143	CcSEcCtD
Atenolol—Shock—Prednisone—hematologic cancer	1.39e-05	0.000142	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—hematologic cancer	1.39e-05	0.000142	CcSEcCtD
Atenolol—Pain—Betamethasone—hematologic cancer	1.38e-05	0.000142	CcSEcCtD
Atenolol—Pain—Dexamethasone—hematologic cancer	1.38e-05	0.000142	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—hematologic cancer	1.38e-05	0.000142	CcSEcCtD
Atenolol—Tachycardia—Prednisone—hematologic cancer	1.37e-05	0.000141	CcSEcCtD
Atenolol—Alopecia—Epirubicin—hematologic cancer	1.37e-05	0.000141	CcSEcCtD
Atenolol—Nausea—Gemcitabine—hematologic cancer	1.37e-05	0.00014	CcSEcCtD
Atenolol—Hyperhidrosis—Prednisone—hematologic cancer	1.36e-05	0.00014	CcSEcCtD
Atenolol—Vision blurred—Methotrexate—hematologic cancer	1.36e-05	0.000139	CcSEcCtD
Atenolol—Rash—Cisplatin—hematologic cancer	1.35e-05	0.000139	CcSEcCtD
Atenolol—Dermatitis—Cisplatin—hematologic cancer	1.35e-05	0.000139	CcSEcCtD
Atenolol—Diarrhoea—Etoposide—hematologic cancer	1.34e-05	0.000138	CcSEcCtD
Atenolol—Anorexia—Prednisone—hematologic cancer	1.34e-05	0.000138	CcSEcCtD
Atenolol—Ill-defined disorder—Methotrexate—hematologic cancer	1.34e-05	0.000137	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—hematologic cancer	1.34e-05	0.000137	CcSEcCtD
Atenolol—Feeling abnormal—Dexamethasone—hematologic cancer	1.33e-05	0.000137	CcSEcCtD
Atenolol—Feeling abnormal—Betamethasone—hematologic cancer	1.33e-05	0.000137	CcSEcCtD
Atenolol—Flushing—Doxorubicin—hematologic cancer	1.33e-05	0.000137	CcSEcCtD
Atenolol—Tension—Epirubicin—hematologic cancer	1.32e-05	0.000136	CcSEcCtD
Atenolol—Nervousness—Epirubicin—hematologic cancer	1.31e-05	0.000134	CcSEcCtD
Atenolol—Malaise—Methotrexate—hematologic cancer	1.3e-05	0.000133	CcSEcCtD
Atenolol—Dizziness—Etoposide—hematologic cancer	1.3e-05	0.000133	CcSEcCtD
Atenolol—Vertigo—Methotrexate—hematologic cancer	1.3e-05	0.000133	CcSEcCtD
Atenolol—Dizziness—Prednisolone—hematologic cancer	1.28e-05	0.000131	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—hematologic cancer	1.28e-05	0.000131	CcSEcCtD
Atenolol—Asthenia—Triamcinolone—hematologic cancer	1.28e-05	0.000131	CcSEcCtD
Atenolol—Body temperature increased—Dexamethasone—hematologic cancer	1.28e-05	0.000131	CcSEcCtD
Atenolol—Body temperature increased—Betamethasone—hematologic cancer	1.28e-05	0.000131	CcSEcCtD
Atenolol—Nausea—Cisplatin—hematologic cancer	1.27e-05	0.000131	CcSEcCtD
Atenolol—Insomnia—Prednisone—hematologic cancer	1.27e-05	0.000131	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—hematologic cancer	1.27e-05	0.00013	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—hematologic cancer	1.27e-05	0.00013	CcSEcCtD
Atenolol—Paraesthesia—Prednisone—hematologic cancer	1.27e-05	0.00013	CcSEcCtD
Atenolol—Pruritus—Triamcinolone—hematologic cancer	1.26e-05	0.000129	CcSEcCtD
Atenolol—Cough—Methotrexate—hematologic cancer	1.26e-05	0.000129	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—hematologic cancer	1.25e-05	0.000128	CcSEcCtD
Atenolol—Dyspepsia—Prednisone—hematologic cancer	1.24e-05	0.000127	CcSEcCtD
Atenolol—Rash—Etoposide—hematologic cancer	1.24e-05	0.000127	CcSEcCtD
Atenolol—Dermatitis—Etoposide—hematologic cancer	1.24e-05	0.000127	CcSEcCtD
Atenolol—Headache—Etoposide—hematologic cancer	1.23e-05	0.000126	CcSEcCtD
Atenolol—Chest pain—Methotrexate—hematologic cancer	1.23e-05	0.000126	CcSEcCtD
Atenolol—Tension—Doxorubicin—hematologic cancer	1.23e-05	0.000126	CcSEcCtD
Atenolol—Decreased appetite—Prednisone—hematologic cancer	1.22e-05	0.000126	CcSEcCtD
Atenolol—Rash—Prednisolone—hematologic cancer	1.22e-05	0.000125	CcSEcCtD
Atenolol—Dermatitis—Prednisolone—hematologic cancer	1.22e-05	0.000125	CcSEcCtD
Atenolol—Malaise—Epirubicin—hematologic cancer	1.22e-05	0.000125	CcSEcCtD
Atenolol—Fatigue—Prednisone—hematologic cancer	1.21e-05	0.000125	CcSEcCtD
Atenolol—Headache—Prednisolone—hematologic cancer	1.21e-05	0.000125	CcSEcCtD
Atenolol—Discomfort—Methotrexate—hematologic cancer	1.21e-05	0.000124	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—hematologic cancer	1.21e-05	0.000124	CcSEcCtD
Atenolol—Vertigo—Epirubicin—hematologic cancer	1.21e-05	0.000124	CcSEcCtD
Atenolol—Syncope—Epirubicin—hematologic cancer	1.21e-05	0.000124	CcSEcCtD
Atenolol—Constipation—Prednisone—hematologic cancer	1.2e-05	0.000124	CcSEcCtD
Atenolol—Palpitations—Epirubicin—hematologic cancer	1.19e-05	0.000122	CcSEcCtD
Atenolol—Confusional state—Methotrexate—hematologic cancer	1.19e-05	0.000122	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—hematologic cancer	1.19e-05	0.000122	CcSEcCtD
Atenolol—Dizziness—Triamcinolone—hematologic cancer	1.18e-05	0.000121	CcSEcCtD
Atenolol—Cough—Epirubicin—hematologic cancer	1.18e-05	0.000121	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—hematologic cancer	1.18e-05	0.000121	CcSEcCtD
Atenolol—Nausea—Etoposide—hematologic cancer	1.17e-05	0.00012	CcSEcCtD
Atenolol—Feeling abnormal—Prednisone—hematologic cancer	1.16e-05	0.000119	CcSEcCtD
Atenolol—Asthenia—Dexamethasone—hematologic cancer	1.16e-05	0.000119	CcSEcCtD
Atenolol—Asthenia—Betamethasone—hematologic cancer	1.16e-05	0.000119	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—hematologic cancer	1.16e-05	0.000119	CcSEcCtD
Atenolol—Thrombocytopenia—Methotrexate—hematologic cancer	1.15e-05	0.000118	CcSEcCtD
Atenolol—Nausea—Prednisolone—hematologic cancer	1.15e-05	0.000118	CcSEcCtD
Atenolol—Chest pain—Epirubicin—hematologic cancer	1.15e-05	0.000118	CcSEcCtD
Atenolol—Anxiety—Epirubicin—hematologic cancer	1.15e-05	0.000117	CcSEcCtD
Atenolol—Pruritus—Dexamethasone—hematologic cancer	1.14e-05	0.000117	CcSEcCtD
Atenolol—Pruritus—Betamethasone—hematologic cancer	1.14e-05	0.000117	CcSEcCtD
Atenolol—Hyperhidrosis—Methotrexate—hematologic cancer	1.14e-05	0.000117	CcSEcCtD
Atenolol—Discomfort—Epirubicin—hematologic cancer	1.14e-05	0.000116	CcSEcCtD
Atenolol—Malaise—Doxorubicin—hematologic cancer	1.13e-05	0.000116	CcSEcCtD
Atenolol—Rash—Triamcinolone—hematologic cancer	1.12e-05	0.000115	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—hematologic cancer	1.12e-05	0.000115	CcSEcCtD
Atenolol—Dermatitis—Triamcinolone—hematologic cancer	1.12e-05	0.000115	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—hematologic cancer	1.12e-05	0.000115	CcSEcCtD
Atenolol—Anorexia—Methotrexate—hematologic cancer	1.12e-05	0.000115	CcSEcCtD
Atenolol—Syncope—Doxorubicin—hematologic cancer	1.12e-05	0.000115	CcSEcCtD
Atenolol—Headache—Triamcinolone—hematologic cancer	1.12e-05	0.000115	CcSEcCtD
Atenolol—Body temperature increased—Prednisone—hematologic cancer	1.11e-05	0.000114	CcSEcCtD
Atenolol—Confusional state—Epirubicin—hematologic cancer	1.11e-05	0.000114	CcSEcCtD
Atenolol—Diarrhoea—Betamethasone—hematologic cancer	1.11e-05	0.000114	CcSEcCtD
Atenolol—Diarrhoea—Dexamethasone—hematologic cancer	1.11e-05	0.000114	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—hematologic cancer	1.1e-05	0.000113	CcSEcCtD
Atenolol—Oedema—Epirubicin—hematologic cancer	1.1e-05	0.000113	CcSEcCtD
Atenolol—Hypotension—Methotrexate—hematologic cancer	1.1e-05	0.000113	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—hematologic cancer	1.1e-05	0.000113	CcSEcCtD
Atenolol—Cough—Doxorubicin—hematologic cancer	1.09e-05	0.000112	CcSEcCtD
Atenolol—Shock—Epirubicin—hematologic cancer	1.08e-05	0.000111	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—hematologic cancer	1.08e-05	0.000111	CcSEcCtD
Atenolol—Tachycardia—Epirubicin—hematologic cancer	1.08e-05	0.00011	CcSEcCtD
Atenolol—Dizziness—Dexamethasone—hematologic cancer	1.07e-05	0.00011	CcSEcCtD
Atenolol—Dizziness—Betamethasone—hematologic cancer	1.07e-05	0.00011	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—hematologic cancer	1.07e-05	0.000109	CcSEcCtD
Atenolol—Insomnia—Methotrexate—hematologic cancer	1.06e-05	0.000109	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—hematologic cancer	1.06e-05	0.000109	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—hematologic cancer	1.06e-05	0.000109	CcSEcCtD
Atenolol—Nausea—Triamcinolone—hematologic cancer	1.06e-05	0.000109	CcSEcCtD
Atenolol—Paraesthesia—Methotrexate—hematologic cancer	1.06e-05	0.000108	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—hematologic cancer	1.05e-05	0.000108	CcSEcCtD
Atenolol—Anorexia—Epirubicin—hematologic cancer	1.05e-05	0.000108	CcSEcCtD
Atenolol—Dyspnoea—Methotrexate—hematologic cancer	1.05e-05	0.000108	CcSEcCtD
Atenolol—Somnolence—Methotrexate—hematologic cancer	1.05e-05	0.000107	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—hematologic cancer	1.04e-05	0.000107	CcSEcCtD
Atenolol—Dyspepsia—Methotrexate—hematologic cancer	1.04e-05	0.000106	CcSEcCtD
Atenolol—Hypotension—Epirubicin—hematologic cancer	1.03e-05	0.000106	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—hematologic cancer	1.03e-05	0.000105	CcSEcCtD
Atenolol—Decreased appetite—Methotrexate—hematologic cancer	1.02e-05	0.000105	CcSEcCtD
Atenolol—Rash—Betamethasone—hematologic cancer	1.02e-05	0.000105	CcSEcCtD
Atenolol—Rash—Dexamethasone—hematologic cancer	1.02e-05	0.000105	CcSEcCtD
Atenolol—Oedema—Doxorubicin—hematologic cancer	1.02e-05	0.000105	CcSEcCtD
Atenolol—Dermatitis—Dexamethasone—hematologic cancer	1.02e-05	0.000105	CcSEcCtD
Atenolol—Dermatitis—Betamethasone—hematologic cancer	1.02e-05	0.000105	CcSEcCtD
Atenolol—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.02e-05	0.000104	CcSEcCtD
Atenolol—Fatigue—Methotrexate—hematologic cancer	1.02e-05	0.000104	CcSEcCtD
Atenolol—Headache—Dexamethasone—hematologic cancer	1.01e-05	0.000104	CcSEcCtD
Atenolol—Headache—Betamethasone—hematologic cancer	1.01e-05	0.000104	CcSEcCtD
Atenolol—Asthenia—Prednisone—hematologic cancer	1.01e-05	0.000104	CcSEcCtD
Atenolol—Pain—Methotrexate—hematologic cancer	1.01e-05	0.000103	CcSEcCtD
Atenolol—Shock—Doxorubicin—hematologic cancer	1e-05	0.000103	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—hematologic cancer	9.98e-06	0.000102	CcSEcCtD
Atenolol—Pruritus—Prednisone—hematologic cancer	9.97e-06	0.000102	CcSEcCtD
Atenolol—Insomnia—Epirubicin—hematologic cancer	9.97e-06	0.000102	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—hematologic cancer	9.95e-06	0.000102	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—hematologic cancer	9.89e-06	0.000101	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—hematologic cancer	9.86e-06	0.000101	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—hematologic cancer	9.82e-06	0.000101	CcSEcCtD
Atenolol—Somnolence—Epirubicin—hematologic cancer	9.8e-06	0.0001	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—hematologic cancer	9.72e-06	9.97e-05	CcSEcCtD
Atenolol—Feeling abnormal—Methotrexate—hematologic cancer	9.7e-06	9.95e-05	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—hematologic cancer	9.7e-06	9.95e-05	CcSEcCtD
Atenolol—Diarrhoea—Prednisone—hematologic cancer	9.64e-06	9.89e-05	CcSEcCtD
Atenolol—Nausea—Betamethasone—hematologic cancer	9.61e-06	9.85e-05	CcSEcCtD
Atenolol—Nausea—Dexamethasone—hematologic cancer	9.61e-06	9.85e-05	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—hematologic cancer	9.58e-06	9.82e-05	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—hematologic cancer	9.53e-06	9.77e-05	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.51e-06	9.76e-05	CcSEcCtD
Atenolol—Fatigue—Epirubicin—hematologic cancer	9.5e-06	9.74e-05	CcSEcCtD
Atenolol—Pain—Epirubicin—hematologic cancer	9.42e-06	9.66e-05	CcSEcCtD
Atenolol—Constipation—Epirubicin—hematologic cancer	9.42e-06	9.66e-05	CcSEcCtD
Atenolol—Dizziness—Prednisone—hematologic cancer	9.32e-06	9.55e-05	CcSEcCtD
Atenolol—Body temperature increased—Methotrexate—hematologic cancer	9.31e-06	9.54e-05	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—hematologic cancer	9.22e-06	9.46e-05	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—hematologic cancer	9.15e-06	9.39e-05	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—hematologic cancer	9.09e-06	9.32e-05	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—hematologic cancer	9.08e-06	9.31e-05	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—hematologic cancer	9.06e-06	9.29e-05	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—hematologic cancer	8.97e-06	9.2e-05	CcSEcCtD
Atenolol—Rash—Prednisone—hematologic cancer	8.88e-06	9.11e-05	CcSEcCtD
Atenolol—Dermatitis—Prednisone—hematologic cancer	8.87e-06	9.1e-05	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—hematologic cancer	8.86e-06	9.09e-05	CcSEcCtD
Atenolol—Headache—Prednisone—hematologic cancer	8.83e-06	9.05e-05	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	8.8e-06	9.03e-05	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—hematologic cancer	8.79e-06	9.01e-05	CcSEcCtD
Atenolol—Constipation—Doxorubicin—hematologic cancer	8.72e-06	8.94e-05	CcSEcCtD
Atenolol—Pain—Doxorubicin—hematologic cancer	8.72e-06	8.94e-05	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—hematologic cancer	8.71e-06	8.93e-05	CcSEcCtD
Atenolol—Asthenia—Methotrexate—hematologic cancer	8.45e-06	8.66e-05	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—hematologic cancer	8.4e-06	8.62e-05	CcSEcCtD
Atenolol—Nausea—Prednisone—hematologic cancer	8.37e-06	8.58e-05	CcSEcCtD
Atenolol—Pruritus—Methotrexate—hematologic cancer	8.33e-06	8.54e-05	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—hematologic cancer	8.06e-06	8.26e-05	CcSEcCtD
Atenolol—Diarrhoea—Methotrexate—hematologic cancer	8.06e-06	8.26e-05	CcSEcCtD
Atenolol—Asthenia—Epirubicin—hematologic cancer	7.91e-06	8.11e-05	CcSEcCtD
Atenolol—Pruritus—Epirubicin—hematologic cancer	7.8e-06	7.99e-05	CcSEcCtD
Atenolol—Dizziness—Methotrexate—hematologic cancer	7.79e-06	7.98e-05	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—hematologic cancer	7.54e-06	7.73e-05	CcSEcCtD
Atenolol—Rash—Methotrexate—hematologic cancer	7.42e-06	7.61e-05	CcSEcCtD
Atenolol—Dermatitis—Methotrexate—hematologic cancer	7.42e-06	7.61e-05	CcSEcCtD
Atenolol—Headache—Methotrexate—hematologic cancer	7.38e-06	7.56e-05	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—hematologic cancer	7.31e-06	7.5e-05	CcSEcCtD
Atenolol—Dizziness—Epirubicin—hematologic cancer	7.29e-06	7.47e-05	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—hematologic cancer	7.21e-06	7.4e-05	CcSEcCtD
Atenolol—Nausea—Methotrexate—hematologic cancer	6.99e-06	7.17e-05	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—hematologic cancer	6.98e-06	7.15e-05	CcSEcCtD
Atenolol—Rash—Epirubicin—hematologic cancer	6.95e-06	7.12e-05	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—hematologic cancer	6.94e-06	7.12e-05	CcSEcCtD
Atenolol—Headache—Epirubicin—hematologic cancer	6.9e-06	7.08e-05	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—hematologic cancer	6.74e-06	6.91e-05	CcSEcCtD
Atenolol—Nausea—Epirubicin—hematologic cancer	6.54e-06	6.71e-05	CcSEcCtD
Atenolol—Rash—Doxorubicin—hematologic cancer	6.43e-06	6.59e-05	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—hematologic cancer	6.42e-06	6.59e-05	CcSEcCtD
Atenolol—Headache—Doxorubicin—hematologic cancer	6.39e-06	6.55e-05	CcSEcCtD
Atenolol—Nausea—Doxorubicin—hematologic cancer	6.06e-06	6.21e-05	CcSEcCtD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	4.85e-06	0.000293	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	4.84e-06	0.000293	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CG—hematologic cancer	4.81e-06	0.000291	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CA9—hematologic cancer	4.81e-06	0.000291	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ACP5—hematologic cancer	4.81e-06	0.000291	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FBXW7—hematologic cancer	4.78e-06	0.000289	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PARP1—hematologic cancer	4.75e-06	0.000287	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOR2—hematologic cancer	4.75e-06	0.000287	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HDAC2—hematologic cancer	4.69e-06	0.000283	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCR4—hematologic cancer	4.69e-06	0.000283	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FBXW7—hematologic cancer	4.68e-06	0.000283	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HDAC2—hematologic cancer	4.59e-06	0.000277	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	4.59e-06	0.000277	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CBL—hematologic cancer	4.57e-06	0.000276	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—IDH1—hematologic cancer	4.52e-06	0.000273	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.52e-06	0.000273	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL3—hematologic cancer	4.52e-06	0.000273	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.49e-06	0.000271	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTO1—hematologic cancer	4.47e-06	0.00027	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCC3—hematologic cancer	4.47e-06	0.00027	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TXN—hematologic cancer	4.47e-06	0.00027	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CBL—hematologic cancer	4.47e-06	0.00027	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CG—hematologic cancer	4.47e-06	0.00027	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTPN1—hematologic cancer	4.45e-06	0.000269	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL3—hematologic cancer	4.42e-06	0.000267	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PTPN11—hematologic cancer	4.39e-06	0.000265	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SPHK1—hematologic cancer	4.38e-06	0.000264	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RASGRP1—hematologic cancer	4.37e-06	0.000264	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	4.37e-06	0.000264	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SYK—hematologic cancer	4.36e-06	0.000263	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HSP90AA1—hematologic cancer	4.36e-06	0.000263	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	4.35e-06	0.000263	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CD—hematologic cancer	4.32e-06	0.000261	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	4.29e-06	0.000259	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	4.28e-06	0.000258	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	4.26e-06	0.000258	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SYK—hematologic cancer	4.26e-06	0.000258	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CREB1—hematologic cancer	4.25e-06	0.000257	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	4.23e-06	0.000256	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.21e-06	0.000254	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT1—hematologic cancer	4.2e-06	0.000254	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCL2—hematologic cancer	4.16e-06	0.000251	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	4.16e-06	0.000251	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6R—hematologic cancer	4.15e-06	0.000251	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.12e-06	0.000249	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT1—hematologic cancer	4.11e-06	0.000248	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CRABP1—hematologic cancer	4.09e-06	0.000247	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.09e-06	0.000247	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3R1—hematologic cancer	4.08e-06	0.000247	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	4.07e-06	0.000246	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	4.06e-06	0.000245	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	3.99e-06	0.000241	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALOX5—hematologic cancer	3.99e-06	0.000241	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	3.99e-06	0.000241	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—JAK2—hematologic cancer	3.97e-06	0.00024	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAP2K1—hematologic cancer	3.95e-06	0.000239	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GRB2—hematologic cancer	3.93e-06	0.000238	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CD—hematologic cancer	3.93e-06	0.000237	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PDGFA—hematologic cancer	3.92e-06	0.000237	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	3.88e-06	0.000235	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KITLG—hematologic cancer	3.87e-06	0.000234	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	3.87e-06	0.000234	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NUP98—hematologic cancer	3.86e-06	0.000233	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GRB2—hematologic cancer	3.85e-06	0.000232	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	3.84e-06	0.000232	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	3.84e-06	0.000232	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KITLG—hematologic cancer	3.78e-06	0.000229	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT5A—hematologic cancer	3.78e-06	0.000228	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.77e-06	0.000228	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ADCY7—hematologic cancer	3.75e-06	0.000226	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOA3—hematologic cancer	3.75e-06	0.000226	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	3.75e-06	0.000226	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NUP214—hematologic cancer	3.72e-06	0.000225	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	3.71e-06	0.000224	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	3.7e-06	0.000223	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	3.69e-06	0.000223	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	3.66e-06	0.000221	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCG2—hematologic cancer	3.65e-06	0.00022	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTR—hematologic cancer	3.65e-06	0.00022	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	3.63e-06	0.000219	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CD86—hematologic cancer	3.62e-06	0.000219	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	3.6e-06	0.000218	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ENO2—hematologic cancer	3.58e-06	0.000216	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HES1—hematologic cancer	3.57e-06	0.000216	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	3.55e-06	0.000215	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CD86—hematologic cancer	3.54e-06	0.000214	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	3.53e-06	0.000213	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	3.51e-06	0.000212	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	3.51e-06	0.000212	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HES1—hematologic cancer	3.5e-06	0.000211	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	3.48e-06	0.00021	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTT1—hematologic cancer	3.47e-06	0.00021	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	3.46e-06	0.000209	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	3.46e-06	0.000209	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	3.46e-06	0.000209	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	3.44e-06	0.000208	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	3.44e-06	0.000208	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	3.42e-06	0.000207	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	3.4e-06	0.000206	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	3.39e-06	0.000205	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	3.39e-06	0.000205	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SDC1—hematologic cancer	3.39e-06	0.000205	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	3.39e-06	0.000205	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	3.39e-06	0.000205	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	3.38e-06	0.000204	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.37e-06	0.000203	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	3.35e-06	0.000202	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	3.33e-06	0.000201	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	3.32e-06	0.0002	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	3.32e-06	0.0002	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.25e-06	0.000196	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	3.17e-06	0.000191	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	3.14e-06	0.00019	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	3.13e-06	0.000189	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	3.1e-06	0.000187	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	3.07e-06	0.000186	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	3.06e-06	0.000185	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	3.06e-06	0.000185	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.04e-06	0.000184	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	2.99e-06	0.000181	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	2.99e-06	0.00018	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	2.92e-06	0.000177	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NQO1—hematologic cancer	2.88e-06	0.000174	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CD44—hematologic cancer	2.88e-06	0.000174	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	2.87e-06	0.000174	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	2.85e-06	0.000172	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	2.81e-06	0.00017	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	2.79e-06	0.000169	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	2.78e-06	0.000168	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	2.76e-06	0.000167	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	2.73e-06	0.000165	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYCS—hematologic cancer	2.73e-06	0.000165	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	2.72e-06	0.000165	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	2.72e-06	0.000165	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.71e-06	0.000164	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	2.7e-06	0.000163	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	2.7e-06	0.000163	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	2.67e-06	0.000161	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	2.67e-06	0.000161	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	2.64e-06	0.00016	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	2.64e-06	0.000159	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	2.64e-06	0.000159	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	2.64e-06	0.000159	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	2.64e-06	0.000159	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	2.59e-06	0.000157	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	2.59e-06	0.000156	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	2.58e-06	0.000156	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	2.58e-06	0.000156	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	2.58e-06	0.000156	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	2.54e-06	0.000153	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	2.53e-06	0.000153	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	2.51e-06	0.000152	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	2.48e-06	0.00015	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	2.47e-06	0.000149	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	2.46e-06	0.000148	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	2.46e-06	0.000148	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	2.45e-06	0.000148	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	2.45e-06	0.000148	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	2.43e-06	0.000147	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTP1—hematologic cancer	2.4e-06	0.000145	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	2.4e-06	0.000145	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	2.4e-06	0.000145	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	2.39e-06	0.000145	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	2.34e-06	0.000141	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	2.32e-06	0.00014	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.3e-06	0.000139	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	2.28e-06	0.000138	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	2.27e-06	0.000137	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	2.27e-06	0.000137	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.25e-06	0.000136	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	2.22e-06	0.000134	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	2.22e-06	0.000134	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTM1—hematologic cancer	2.21e-06	0.000133	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOR1—hematologic cancer	2.21e-06	0.000133	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	2.19e-06	0.000132	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	2.17e-06	0.000131	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	2.14e-06	0.000129	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	2.13e-06	0.000129	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	2.09e-06	0.000126	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	2.08e-06	0.000126	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	2.08e-06	0.000126	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	2.04e-06	0.000123	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	2.03e-06	0.000123	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	2.02e-06	0.000122	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	2.02e-06	0.000122	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	1.98e-06	0.000119	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	1.98e-06	0.000119	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTHFR—hematologic cancer	1.95e-06	0.000118	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	1.93e-06	0.000117	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	1.9e-06	0.000115	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	1.89e-06	0.000114	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	1.88e-06	0.000113	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	1.86e-06	0.000112	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	1.86e-06	0.000112	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	1.86e-06	0.000112	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	1.85e-06	0.000112	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	1.84e-06	0.000111	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	1.82e-06	0.00011	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	1.82e-06	0.00011	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	1.81e-06	0.000109	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	1.81e-06	0.000109	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	1.81e-06	0.000109	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	1.77e-06	0.000107	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	1.77e-06	0.000107	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	1.75e-06	0.000106	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	1.75e-06	0.000106	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	1.71e-06	0.000103	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	1.71e-06	0.000103	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	1.71e-06	0.000103	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	1.7e-06	0.000103	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	1.67e-06	0.000101	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	1.67e-06	0.000101	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	1.67e-06	0.000101	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.64e-06	9.91e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	1.63e-06	9.85e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	1.62e-06	9.79e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	1.58e-06	9.58e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	1.58e-06	9.53e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	1.56e-06	9.44e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	1.56e-06	9.42e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	1.54e-06	9.33e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	1.53e-06	9.23e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	1.52e-06	9.21e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CREBBP—hematologic cancer	1.52e-06	9.19e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	1.49e-06	9.02e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	1.46e-06	8.82e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	1.45e-06	8.77e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	1.45e-06	8.75e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.44e-06	8.71e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALB—hematologic cancer	1.42e-06	8.6e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	1.42e-06	8.58e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	1.42e-06	8.56e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.36e-06	8.23e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	1.34e-06	8.1e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	1.31e-06	7.93e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.26e-06	7.59e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	1.23e-06	7.45e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	1.21e-06	7.28e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	1.19e-06	7.2e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	1.17e-06	7.05e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	1.14e-06	6.89e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	1.12e-06	6.74e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	1.09e-06	6.59e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTEN—hematologic cancer	1.09e-06	6.56e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	1.07e-06	6.45e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—EP300—hematologic cancer	1.04e-06	6.26e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	1.01e-06	6.08e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	9.85e-07	5.95e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.66e-07	4.63e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKT1—hematologic cancer	6.26e-07	3.78e-05	CbGpPWpGaD
